 | • レポートコード：B-MOR-040828 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、眼科用薬剤および装置の世界市場について調べ、眼科用薬剤および装置の世界規模、市場動向、市場環境、手術装置別（緑内障手術装置、白内障手術装置、屈折矯手術用、網膜硝子体手術用、診断・モニタリング装置）分析、薬剤別（抗緑内障の治療剤、眼の感染症治療剤、眼科用炎症治療剤、眼科用潤滑剤、散瞳の治療剤、眼のはれものの治療剤）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・眼科用薬剤および装置の世界市場インサイト ・眼科用薬剤および装置の世界市場環境 ・眼科用薬剤および装置の世界市場動向 ・眼科用薬剤および装置の世界市場規模 ・眼科用薬剤および装置の世界市場規模：手術装置別（緑内障手術装置、白内障手術装置、屈折矯手術用、網膜硝子体手術用、診断・モニタリング装置） ・眼科用薬剤および装置の世界市場規模：薬剤別（抗緑内障の治療剤、眼の感染症治療剤、眼科用炎症治療剤、眼科用潤滑剤、散瞳の治療剤、眼のはれものの治療剤） ・眼科用薬剤および装置の世界市場：地域別市場規模・分析 ・眼科用薬剤および装置の北米市場規模・予測 ・眼科用薬剤および装置のアメリカ市場規模・予測 ・眼科用薬剤および装置のヨーロッパ市場規模・予測 ・眼科用薬剤および装置のアジア市場規模・予測 ・眼科用薬剤および装置の日本市場規模・予測 ・眼科用薬剤および装置の中国市場規模・予測 ・眼科用薬剤および装置のインド市場規模・予測 ・眼科用薬剤および装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
Ophthalmology is a branch of medicine that deals with the anatomy, physiology, and diseases of the eye. An ophthalmologist is a specialist in medical and surgical eye problems, who performs operations on eyes. They are specially trained to provide the full spectrum of eye care, from prescribing glasses and contact lenses to complex and delicate eye surgery. The devices include glasses, lenses, diagnostics, lasers, solutions, and surgical instruments. The global ophthalmology drug and device market is expected to register a CAGR of 5.3% during the forecast period of 2018-2023.
Growth in Cataract Volume
Cataract volume has registered a rapid increase in the recent years. The aging population is expected to burden all areas of health care, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. Cataract surgery is the most frequent surgical procedure performed in many countries and provides significant improvements in quality of life, to elderly population at low costs.
With an increase in the demand for ophthalmological devices, projecting future cataract surgery needs are vital for health human resource, hospital, and surgical center management and planning.
Other factors, such as availability of new drugs and devices and prevalence of eye disease are expected to drive the market over the forecast period.
Strict FDA Guidelines for Drug Approval
There are many regulations by agencies, such as the FDA, to ensure the safety and efficacy of products. Tighter regulations on the label contents are being seriously enforced, as there were frequent occurrences of violations.
The cost of complying with FDA guidelines is expected to drive many small pharmacies out of business or force them to consolidate. For example, these regulations would impose a beyond-use date for bevacizumab and other biologics of only five days, but it takes 14 days just to test the sterility of these drugs, which means the regulations for compounded ophthalmology drugs besides bevacizumab, such as ophthalmology mitomycin, and triamcinolone acetonide plus moxifloxacin hydrochloride injection, will become much more expensive or even unavailable.
Additionally, increasing healthcare cost and economic slowdown in developed countries are also restraining the market’s growth.
North America to Dominate the Market
The ophthalmology drug and device market has been segmented by surgical device, drug, and geography. By surgical device, the market has been segmented into glaucoma surgery devices, cataract surgery devices, refractive surgery devices, vitreoretinal surgery devices, and diagnostic & monitoring devices. By drug, the market has been segmented into anti glaucoma drugs, ophthalmology infection drugs, ophthalmology inflammation drugs, ophthalmology lubricants, mydriasis drugs, and ophthalmology swelling. By geography, the market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
Due to the presence of well-established healthcare facilities and the rise in geriatric population in the region, North America dominates the ophthalmology drug and device market.
Key Developments in the Market
• November 2017: Bausch & Lomb got Vyzulta approved for reduction of intraocular pressure, in patients with open-angle glaucoma or ocular hypertension.
• November 2017: Zeiss introduced cloud-based cataract surgery planning platform, Veracity Surgical, and announced the integration with leading EMRs.
Major Players – CARL ZEISS MEDITEC AG, ALCON INC., JOHNSON & JOHNSON, TOPCON CORPORATION, NIDEK CO. LTD, HAAG-STREIT GROUP, ZIEMER OPHTHALMOLOGY SYSTEMS AG, ESSILOR INTERNATIONAL SA, BAUSCH & LOMB INC., amongst others.
Reasons to Purchase This Report
• Analysis of the global ophthalmology drug and device market, with region-specific assessments and competition analysis on global and regional scales.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis.
• The treatment type that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porter’s Five Force Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Degree of Competition
5.3.4 Threat of Substitution
5.3.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Demographic Shift and Impact of Prevalence of Eye Disease
6.1.2 Availability of New Drugs and Devices
6.1.3 Growth in Cataract Volume
6.2 Market Restraints
6.2.1 Increasing Healthcare Costs
6.2.2 Economic Slowdown in Developed Markets
6.2.3 Strict FDA Guidelines for Drug Approval
6.3 Opportunities
6.4 Challenges
7. Market Segmentation
7.1 Surgical Devices
7.1.1 Glaucoma Surgery Devices
7.1.1.1 Glaucoma Drainage Devices
7.1.1.2 Glaucoma Lasers
7.1.1.3 Glaucoma Stents and Implants
7.1.1.4 Others
7.1.2 Cataract Surgery Devices
7.1.2.1 Intraocular Lenses
7.1.2.2 Phacoemulsification Devices
7.1.2.3 Ophthalmic Viscoelastic Devices
7.1.3 Refractive Surgery Devices
7.1.3.1 Microkeratomers
7.1.3.2 Lasers
7.1.4 Vitreoretinal Surgery Devices
7.1.4.1 Photocoagulation Lasers
7.1.4.2 Illumination Devices
7.1.4.3 Vitrectomy Machines & Packs
7.1.4.4 Other Vitreoretinal Surgery Devices
7.1.5 Diagnostic & Monitoring Devices
7.1.5.1 Fundus Cameras
7.1.5.2 Ophthalmoscopes
7.1.5.3 Retinoscopes
7.1.5.4 Keratometers
7.1.5.5 Tonometers
7.1.5.6 Wavefront Aberrometers
7.1.5.7 Corneal Topography
7.1.5.8 Autorefractors
7.1.5.9 Visual Field Analyzers
7.1.5.10 Slit Lamps
7.1.5.11 Optical Coherence Tomography Scanners
7.1.5.12 Ophthalmic Ultrasound Imaging Systems
7.1.5.13 Other Diagnostic & Monitoring Devices
7.2 By Drugs
7.2.1 Anti Glaucoma Drugs
7.2.2 Ophthalmic Infection Drugs
7.2.3 Ophthalmic Inflammation Drugs
7.2.4 Ophthalmic Lubricants
7.2.5 Mydriasis Drugs
7.2.6 Ophthalmic Swelling
7.3 By Geography
7.3.1 North America
7.3.1.1 US
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 Germany
7.3.2.2 UK
7.3.2.3 France
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest Of Europe (RoE)
7.3.3 Asia Pacific
7.3.3.1 Japan
7.3.3.2 China
7.3.3.3 India
7.3.3.4 South Korea
7.3.3.5 Australia
7.3.3.6 Rest Of Asia Pacific
7.3.4 The Middle East & Africa
7.3.4.1 GCC Countries
7.3.4.2 South Africa
7.3.4.3 Rest Of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest Of South America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 Carl Zeiss Meditec AG
9.2 Alcon Inc.
9.3 Johnson And Johnson
9.4 Topcon Corporation
9.5 Nidek Co. Ltd.
9.6 Haag-Streit Group
9.7 Ziemer Ophthalmic Systems AG
9.8 Essilor International S.A.
9.9 Bausch & Lomb Inc.
10. Future of the Market